Company Name | Senores Pharmaceuticals Limited |
Open Date | 20-12-2024 |
Close Date | 24-12-2024 |
Exchange | BSE, NSE |
Lot Size | 38 Shares |
Issue Price | ₹372 to ₹391 per share |
Issue Size | 1,48,87,723 shares |
Application Amount | ₹ 14,858 – ₹ 1,93,154 (38 to 494 shares) |
Recommendation | Apply |
Incorporation: Senores Pharmaceuticals Limited
was originally incorporated on December 26, 2017.
The company has its registered office in Ahmedabad,
Gujarat, India.
▪ Business Activity: The company is global research
driven pharmaceutical company engaged in
developing and manufacturing a wide range of generic
pharmaceutical products in the B2B segment
predominantly for the Regulated Markets across
various therapeutic areas and dosage forms.
▪ Human Resource: The company had 145 employees
as of Sep 30, 2024.
KPI’s | FY 22 | FY 23 | FY 24 | FY-25* |
Revenue | 14.17 | 35.34 | 214.52 | 362.04 |
EBITDA | 1.95 | 12.67 | 41.59 | 89.15 |
Net Profit | 0.99 | 8.43 | 32.71 | 47.89 |
RoCE | 2.53% | 13.76% | 8.43% | 10.55% |
ROE | 2.71% | 18.53% | 14.12% | 5.68% |
P/E | 216.02 | 58.80 | 32.02 | 37.60 |
Opening Date | 20/12/2024 |
Closing Date | 24-12-2024 |
Basis of Allotment | 26-12-2024 |
Initiation of Refunds | 27-12-2024 |
Credit of Shares to Demat | 27-12-2024 |
Listing Date | 30-12-2024 |
Repayment/pre-payment, in full or in part, of certain borrowings availed by the Company. |
Investment in the Subsidiary, namely, Havix, for repayment/pre-payment of certain borrowings. |
Funding the working capital requirements of the Company |
Investment in the Subsidiaries, namely, Senores Pharmaceuticals Inc. (“SPI”) and Ratnatris Pharmaceutical Private Limited (“Ratnatris”), to fund their working capital requirements. |
Funding inorganic growth through acquisition and other strategic initiatives |
Repayment/prepayment, in part or full, of certain of borrowings availed by the company. - For payment of interest accrued thereon; and - Step-down Subsidiaries, namely SS & L Beach Private Limited and Maldives Property Holdings Private Limited, including the payment of interest thereon through investment in such step-down Subsidiaries |
Offer For Sale |
General corporate purposes |
Registered Office | Senores Pharmaceuticals Limited 1101 to 1103, 11th floor, South Tower, ONE 42 oppositeJayantilal Park, Ambali Bopal Road, Ahmedabad,-380054 |
Phone | +91-79-29999857 |
cs@senorespharma.com | |
Website | https://senorespharma.com/ |
Name | Link Intime India Private Limited |
Phone | +91-22-4918 6270 |
senorespharma.ipo@linkintime.co.in | |
Website | https://linkintime.co.in/mipo/ipoallotment.html |
Anchor Investor Shares Offered | 66,65,725 (45%) |
QIB Shares Offered | 44,43,817 (30%) |
Retail Shares Offered | 14,81,272 (10%) |
NII (HNI) Shares Offered | 22,21,909 (15%) |
Total Shares Offered | 1,48,12,723 (100%) |
Share Holding Pre Issue (Promoters) | 66.66% |
Share Holding Post Issue (Promoters) | 45.76% |